Asmaclear
Brand Name: Asmaclear
Generic Name: Guaifenesin + Salbutamol (As Sulfate)
Active
Registration Number
DRP-2122-01
Dosage Form
Capsule
Issuance Date
May 31, 2022
Expiry Date
July 12, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 mg/2 mg
PackagingClear PVC Blister Pack by 10's (Box of 100's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Expectorant/Bronchodilator
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
GuaifenesinActive
Monograph: Guaifenesin
Salbutamol (As Sulfate)Active
Monograph: R-salbutamol sulphate